Gastric cancer found on 3′-deoxy-3′ F-18 fluorothymidine positron emission tomography

Clinical Nuclear Medicine

Volumn 33, Issue 9, 2008, Pages 641-642

  Koizumi, Mitsuru ^a,c   Saga, Tsuneo ^a   Yoshikawa, Kyosan ^b   Baba, Masayuki ^b  

^a Natl Inst Radiol Sci   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

FLT; Gastric cancer; PET

Indexed keywords

3' FLUOROTHYMIDINE F 18; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3' FLUOROTHYMIDINE; DIAGNOSTIC AGENT;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; GASTROSCOPE; HUMAN; ION THERAPY; LUNG SQUAMOUS CELL CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE DISTRIBUTION; SECOND CANCER; STOMACH CANCER; INCIDENTAL FINDING; SCINTISCANNING; STOMACH TUMOR;

AGED; DIDEOXYNUCLEOSIDES; HUMANS; INCIDENTAL FINDINGS; MALE; POSITRON-EMISSION TOMOGRAPHY; STOMACH NEOPLASMS;

EID: 55449137287     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318181534b     Document Type: Article

References (8)

1. Salskov A, Tammisetti VS, Grierson J, et al. FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3′- [18F]fluorothymidine. Semin Nucl Med. 2007;37:429-439.
2. Yamamoto Y, Nishiyama Y, Ishikawa S, et al. Correlation of (18)F-FLT and (18)F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2007;34:1610-1606.
3. Saga T, Kawashima H, Araki N, et al. Evaluation of primary brain tumors with FLT-PET: usefulness and limitations. Clin Nucl Med. 2006;31:774-780.
4. Buck AK, Bommer M, Sulgenbauer S, et al. Molecular imaging of proliferation in malignant lymphoma. Cancer Res. 2006;66:11055-11061.
5. Kenny LM, Vigushin DM, Al-Nahhas A, et al. Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. Cancer Res. 2005;65:10104-10112.
6. Francis DL, Visvikis D, Costa DC, et al. Potential impact of [18F]3-deoxy-3′-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer. Eur J Nucl Med Mol Imaging. 2003;30:988-994.
7. van Westreenen HL, Cobben DC, Jager PL, et al. Comparison of 18FFLT PET and 18F-FDG PET in esophageal cancer. J Nucl Med. 2005;46:400-404.
8. Cobben DC, van der Laan BF, Maas B, et al. 18F-FLT PET for visualizationof laryngeal cancer: comparison with 18F-FDG PET. J Nucl Med. 2004;45:226-231.